1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (011) 81-4-7134-7026.
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy
Article first published online: 27 NOV 2006
DOI: 10.1002/cncr.22368
Copyright © 2006 American Cancer Society
Additional Information
How to Cite
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y. and and The Breast Cancer Survivors' Brain MRI Database Group (2007), Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109: 146–156. doi: 10.1002/cncr.22368
Publication History
- Issue published online: 11 DEC 2006
- Article first published online: 27 NOV 2006
- Manuscript Accepted: 6 OCT 2006
- Manuscript Revised: 4 OCT 2006
- Manuscript Received: 6 SEP 2006
Funded by
- Japanese Ministry of Health, Labor, and Welfare
- Japan Society for the Promotion of Science
- Japanese Ministry of Education, Culture, Science, and Technology
- Foundation for Promotion of Cancer Research in Japan
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Chemotherapy-Related Cognitive Dysfunction, Current Neurology and Neuroscience Reports, 2012, 12, 3, 267
- 2, , , , , , , , , Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation, Cancer, 2012, 118, 11Direct Link:
- 3, , Cognitive function and quality of life in ovarian cancer, Gynecologic Oncology, 2012, 124, 3, 404
- 4, , , , , Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study, Brain, Behavior, and Immunity, 2012,
- 5, , , , , , , , , , , Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging, Human Brain Mapping, 2012, 33, 6Direct Link:
- 6, , , , , Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives, Cancer Investigation, 2012, 30, 2, 135
- 7, , , , , Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study, Journal of Clinical and Experimental Neuropsychology, 2012, 34, 5, 543
- 8, , , Review of recent studies on interventions for cognitive deficits in patients with cancer, Expert Review of Anticancer Therapy, 2012, 12, 2, 255
- 9, , , , The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats, Behavioural Brain Research, 2012, 227, 1, 295
- 10, , , , Analysis of Memory Deficits Following Chemotherapy in Breast Cancer Survivors: Evidence from the Doors and People Test, Journal of Psychosocial Oncology, 2011, 29, 5, 499
- 11, , , , Chemotherapy and Cognitive Impairment: Treatment Options, Clinical Pharmacology & Therapeutics, 2011, 90, 3, 366
- 12, , , , , , , , , , , , , Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients, Human Brain Mapping, 2011, 32, 3Direct Link:
- 13, , , Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model, Neuropharmacology, 2011, 61, 8, 1222
- 14, , , , , Either Called “Chemobrain†or “Chemofog,†the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real, Journal of Pain and Symptom Management, 2011, 41, 1, 126
- 15, , , , , , , , , , Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy, Breast Cancer Research and Treatment, 2011, 132, 3, 1099
- 16, , , , , , Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature, Psycho-Oncologie, 2011, 5, 1, 3
- 17, , , , , , , Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy, European Journal of Cancer, 2011, 47, 17, 2531
- 18, , , , International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, 2011, 12, 7, 703
- 19, , , , , , Cognitive functions in long-term survivors of ovarian cancer, Gynecologic Oncology, 2010, 119, 2, 366
- 20, , , , , , , Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy, Psychopharmacology, 2010, 215, 1, 105
- 21, , , , , Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study, Breast Cancer Research and Treatment, 2010, 123, 3, 819
- 22, , , , , , , , , , IGF-1 Partially Restores Chemotherapy-Induced Reductions in Neural Cell Proliferation in Adult C57BL/6 Mice, Cancer Investigation, 2010, 28, 5, 544
- You have free access to this content23, Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in ‘chemo-fog’/’chemo-brain’, Journal of Clinical Pharmacy and Therapeutics, 2010, 35, 1Direct Link:
- 24, , , , Manganese superoxide dismutase: beyond life and death, Amino Acids, 2010, 42, 1, 139
- 25, , , Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer, Psycho-Oncology, 2010, 19, 5Direct Link:
- 26, , The fog hasn’t lifted on “chemobrain†yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition, Breast Cancer Research and Treatment, 2010, 123, 1, 35
- 27, , , , , Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment, Southern Medical Journal, 2009, 102, 9, 929
- 28, Chemotherapy-Related Cognitive Impairment, Clinical Journal of Oncology Nursing, 2009, 13, 4, 413
- 29, , , , , , CNS complications of radiotherapy and chemotherapy, The Lancet, 2009, 374, 9701, 1639
- 30, , Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer, Australian Psychologist, 2009, 44, 4Direct Link:
- 31, , , , Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution, International Journal of Radiation Oncology*Biology*Physics, 2009, 73, 3, 752
- 32, , , Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory, Psychopharmacology, 2008, 199, 4, 527
- 33, , , , , , , ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy, Clinical Neurophysiology, 2008, 119, 3, 533
- 34
- 35, , , Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy, Neuropsychology Review, 2008, 18, 2, 121
- 36, , , , , , , , , , , , Prospective Evaluation of Quality of Life and Neurocognitive Effects in Patients With Multiple Brain Metastases Receiving Whole-Brain Radiotherapy With or Without Thalidomide on Radiation Therapy Oncology Group (RTOG) Trial 0118, International Journal of Radiation Oncology*Biology*Physics, 2008, 71, 1, 71
- 37, , , Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy, Lung Cancer, 2008, 62, 3, 391
- 38
- 39, , Cognitive adverse effects of chemotherapy in breast cancer patients, Current Opinion in Supportive and Palliative Care, 2007, 1, 1, 57
- 40, , , Cognitive dysfunction associated with chemotherapy for breast cancer, Future Neurology, 2007, 2, 3, 271
- 41, , Cognitive function after chemotherapy in adults with solid tumours, Critical Reviews in Oncology/Hematology, 2007, 63, 3, 183
- 42, , , Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy, Cancer, 2007, 110, 1Direct Link: